Cite
Immunological evaluation of personalized peptide vaccination with gemcitabine for advance pancreatic cancer patients
MLA
Souichirou Takai, et al. “Immunological Evaluation of Personalized Peptide Vaccination with Gemcitabine for Advance Pancreatic Cancer Patients.” Journal of Clinical Oncology, vol. 24, June 2006, p. 14029. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........74d3a2472b0659b29c9070378fba764a&authtype=sso&custid=ns315887.
APA
Souichirou Takai, Takashi Mine, Yasuo Kamiyama, K. Yamamoto, S. Satoi, Masaaki Oka, J. Mizoguchi, Kyogo Itoh, Akira Yamada, Hiroaki Yanagimoto, & S. Honma. (2006). Immunological evaluation of personalized peptide vaccination with gemcitabine for advance pancreatic cancer patients. Journal of Clinical Oncology, 24, 14029.
Chicago
Souichirou Takai, Takashi Mine, Yasuo Kamiyama, K. Yamamoto, S. Satoi, Masaaki Oka, J. Mizoguchi, et al. 2006. “Immunological Evaluation of Personalized Peptide Vaccination with Gemcitabine for Advance Pancreatic Cancer Patients.” Journal of Clinical Oncology 24 (June): 14029. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........74d3a2472b0659b29c9070378fba764a&authtype=sso&custid=ns315887.